Outcomes Research in Review

Coronary CT Angiography Compared to Coronary Angiography or Standard of Care in Patients With Intermediate-Risk Stable Chest Pain


 

References

Study 2 Overview (DISCHARGE Trial Group)

Objective: To compare the effectiveness of computed tomography (CT) with ICA as a diagnostic tool in patients with stable chest pain and intermediate pretest probability of coronary artery disease (CAD).

Design: Multicenter, randomized, assessor-blinded pragmatic prospective study.

Setting and participants: A total of 3667 patients with stable chest pain and intermediate pretest probability of CAD were enrolled at 26 centers and randomized into CT or ICA groups. Only 3561 patients were included in the modified intention-to-treat analysis, with 1808 patients and 1753 patients in the CT and ICA groups, respectively.

Main outcome measures: The primary outcome was a composite of cardiovascular death, nonfatal myocardial infarction, and nonfatal stroke over 3.5 years. The main secondary outcomes were major procedure-related complications and patient-reported angina pectoris during the last 4 weeks of follow up.

Main results: The primary outcome occurred in 38 of 1808 patients (2.1%) in the CT group and in 52 of 1753 patients (3.0%) in the ICA group (hazard ratio, 0.70; 95% CI, 0.46-1.07; P = .10). The secondary outcomes showed that major procedure-related complications occurred in 9 patients (0.5%) in the CT group and in 33 patients (1.9%) in the ICA group (hazard ratio, 0.26; 95% CI, 0.13-0.55). Rates of patient-reported angina in the final 4 weeks of follow-up were 8.8% in the CT group and 7.5% in the ICA group (odds ratio, 1.17; 95% CI, 0.92-1.48).

Conclusion: Risk of major adverse cardiovascular events from the primary outcome were similar in both the CT and ICA groups among patients with stable chest pain and intermediate pretest probability of CAD. Patients referred for CT had a lower rate of coronary angiography leading to fewer major procedure-related complications in these patients than in those referred for ICA.

Recommended Reading

Lowering BP according to newest guidance would cut CV events
Journal of Clinical Outcomes Management
Pfizer recalls more quinapril because of potential carcinogen
Journal of Clinical Outcomes Management
Will you have cardiac arrest? New tech may predict if and when
Journal of Clinical Outcomes Management
Cutting dementia risk in AFib: Does rhythm control strategy matter?
Journal of Clinical Outcomes Management
‘Embarrassing’: High-intensity statin uptake in ASCVD patients ‘terrible’
Journal of Clinical Outcomes Management
Takotsubo syndrome also linked to happy life events
Journal of Clinical Outcomes Management
Mixing BP meds with NSAID may be ‘triple whammy’ for kidneys
Journal of Clinical Outcomes Management
ESG’s cardiometabolic benefits last 5 years
Journal of Clinical Outcomes Management
SGLT2 inhibitors as first-line therapy in type 2 diabetes?
Journal of Clinical Outcomes Management
Paradigm-challenging heart failure treatment strategy hopeful in early trial
Journal of Clinical Outcomes Management